CA
ZBH icon

CSM Advisors’s Zimmer Biomet ZBH Stock Holding History

CSM Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$765K Buy
8,884
+806
+10% +$70.7K 0.02% 357
2026
Q1 		$730K Buy
8,078
+595
+8% +$54.6K 0.02% 353
2025
Q4 		$672K Buy
7,483
+683
+10% +$64.8K 0.02% 354
2025
Q3 		$670K Buy
6,800
+3,226
+90% +$320K 0.02% 358
2025
Q2 		$326K Buy
+3,574
New +$346K 0.01% 358

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CSM Advisors's ZBH Position: Q2 2026 in Review

CSM Advisors increased its Zimmer Biomet (ZBH) stake by 10% in Q2 2026, buying an estimated $70.7K and bringing the position to 8,884 shares worth $765K. The position accounts for 0.02% of the portfolio, ranked #357.

CSM Advisors first reported a position in ZBH in Q2 2025 and has held it in 5 quarters since. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • CSM Advisors held 8,884 shares of Zimmer Biomet worth $765K as of Q2 2026.
  • CSM Advisors bought 806 Zimmer Biomet shares in Q2 2026, an estimated $70.7K.
  • Zimmer Biomet made up 0.02% of CSM Advisors's portfolio in Q2 2026, its #357 holding.
  • CSM Advisors first reported a position in Zimmer Biomet in Q2 2025 and has held it in 5 quarters since.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.